Thomas Ulich

2014

In 2014, Thomas Ulich earned a total compensation of $1.3M as Chief Scientific Officer at InVivo Therapeutics Holdings.

Compensation breakdown

Non-Equity Incentive Plan$52,500
Option Awards$1,015,924
Salary$201,231
Stock Awards$22,500
Other$47,431
Total$1,339,586

Ulich received $1M in option awards, accounting for 76% of the total pay in 2014.

Ulich also received $52.5K in non-equity incentive plan, $201.2K in salary, $22.5K in stock awards and $47.4K in other compensation.

Rankings

In 2014, Thomas Ulich's compensation ranked 6,284th out of 13,032 executives tracked by ExecPay. In other words, Ulich earned more than 51.8% of executives.

ClassificationRankingPercentile
All
6,284
out of 13,032
52nd
Division
Manufacturing
2,290
out of 4,966
54th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
280
out of 736
62nd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
151
out of 446
66th
Industry
Surgical and Medical Instruments and Apparatus
81
out of 275
71st
Source: SEC filing on April 25, 2017.

Ulich's colleagues

We found four more compensation records of executives who worked with Thomas Ulich at InVivo Therapeutics Holdings in 2014.

2014

Mark Perrin

InVivo Therapeutics Holdings

Chief Executive Officer

2014

Tamara Joseph

InVivo Therapeutics Holdings

General Counsel

2014

Steven McAllister

InVivo Therapeutics Holdings

Chief Financial Officer

2014

Michael Astrue

InVivo Therapeutics Holdings

Chief Executive Officer

In-depth

You may also like